We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAN
3451
Canaan Creative
CAN
$159M
$15.9K ﹤0.01%
8,748
+3,608
+70% +$8.51K
RAIN
3452
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$15.8K ﹤0.01%
18,317
+2,857
+18% +$3.13K
BLZE icon
3453
Backblaze
BLZE
$1.16B
$15.6K ﹤0.01%
2,833
AHG
3454
Akso Health Group
AHG
$1.16B
$15.5K ﹤0.01%
14,447
-5,493
-28% -$3.15K
ENZL icon
3455
iShares MSCI New Zealand ETF
ENZL
$82.9M
$14.9K ﹤0.01%
337
ZIM icon
3456
ZIM Integrated Shipping Services
ZIM
$3.24B
$14.6K ﹤0.01%
1,401
+578
+70% +$7.35K
OPY icon
3457
Oppenheimer Holdings
OPY
$1.2B
$14.6K ﹤0.01%
380
-281
-43% -$10.9K
LWAY icon
3458
Lifeway Foods
LWAY
$481M
$14.5K ﹤0.01%
1,400
GENE
3459
DELISTED
Genetic Technologies Ltd.
GENE
$14.4K ﹤0.01%
3,740
AIH
3460
DELISTED
Aesthetic Medical International Holdings
AIH
$14.4K ﹤0.01%
20,115
+8,120
+68% +$6.94K
SHCO
3461
DELISTED
Soho House & Co
SHCO
$14.3K ﹤0.01%
2,061
SEO
3462
DELISTED
STORA ENSO OYJ, ADS(RP 1 SR R)
SEO
$14K ﹤0.01%
1,107
+516
+87% +$6.53K
GRPN icon
3463
Groupon
GRPN
$1.02B
$13.8K ﹤0.01%
903
-1,118
-55% -$10.9K
TUYA
3464
Tuya Inc
TUYA
$1.1B
$13.8K ﹤0.01%
8,925
+6,190
+226% +$9.9K
GIL icon
3465
Gildan
GIL
$10.6B
$13.6K ﹤0.01%
484
-70
-13% -$2.1K
LTRX icon
3466
Lantronix
LTRX
$266M
$13.1K ﹤0.01%
2,937
MTL
3467
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$13K ﹤0.01%
5,800
BNTX icon
3468
BioNTech
BNTX
$23.5B
$13K ﹤0.01%
120
AVDL
3469
DELISTED
Avadel Pharmaceuticals
AVDL
$12.9K ﹤0.01%
1,256
-65
-5% -$871
ADAG
3470
Adagene
ADAG
$272M
$12.9K ﹤0.01%
8,965
+6,750
+305% +$9.24K
CNTB
3471
Connect Biopharma Holdings
CNTB
$139M
$12.8K ﹤0.01%
16,520
+6,585
+66% +$6K
CAE icon
3472
CAE Inc. Common Shares
CAE
$8.74B
$12.7K ﹤0.01%
546
-155
-22% -$3.58K
TOUR
3473
Tuniu
TOUR
$55.6M
$12.7K ﹤0.01%
1,054
AIXI
3474
Xiao-I
AIXI
$1.03M
$12.5K ﹤0.01%
36
+15
+71% +$12.1K
BZUN
3475
Baozun
BZUN
$172M
$12.4K ﹤0.01%
4,003
+400
+11% +$1.6K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.